Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × tipifarnib × 90 days × Clear all

Sponsor

Conditions

Neuroblastoma 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hepatoblastoma 1 Head and Neck Neoplasms 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1

Interventions

Dasatinib 3 nilotinib 2 asciminib 2 ruxolitinib 1 ponatinib 1 pembrolizumab 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Practice Management, Medical 1 Polymerase Chain Reaction 1 Mycophenolic Acid 1 Methotrexate 1 Interviews as Topic 1 Imatinib Mesylate 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Cyclosporine 1 Cyclophosphamide 1 Blood Specimen Collection 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡